In modern-day medicine, nanotechnology and nanoparticles are some of the indispensable
tools in disease monitoring and therapy. The term “nanomaterials” describes materials with …

Cancer remains one of the world's leading causes of death. However, most conventional
chemotherapeutic drugs only show a narrow therapeutic window in patients because of their …

Despite the enormous therapeutic potential of immune checkpoint blockade (ICB), it benefits
only a small subset of patients. Some chemotherapeutics can switch 'immune-cold'tumours …

During the past few decades, polymeric micelles have raised special attention as novel
nano-sized drug delivery systems for optimizing the treatment and diagnosis of numerous …

Metal nanoparticles (NPs) may have the potential to overcome problems related to
conventional chemotherapy. Metal NPs reported to play a beneficial and powerful role in …

Nanomedicine of synergistic drug combinations has shown increasing significance in
cancer therapy due to its promise in providing superior therapeutic benefits to the current …

Lipid nanoparticles (LNPs) have emerged as a powerful non-viral carrier for drug delivery.
With the prevalence of respiratory diseases, particularly highlighted by the current COVID-19 …

Cancer affects millions of people worldwide, and it is projected that there will be 1,958,310
new cancer cases and 609,820 cancer fatalities in the United States in 2023. Epirubicin …

RNA-interference (RNAi) agents such as small-interfering RNA (siRNA) and micro-RNA
(miRNA) have strong potential as therapeutic agents for the treatment of a broad range of …

Molecular imprinting polymers (MIPs) is an artificial receptor of target molecules and
functions as biomimetic way of natural antibody-antigen systems. Their mechanism can be …